Metronidazole and Pathogen resistance - a phase IV clinical study of FDA data
Summary:
Pathogen resistance is found among people who take Metronidazole, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Metronidazole and have Pathogen resistance. It is created by eHealthMe based on reports of 43,868 people who have side effects when taking Metronidazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
43,868 people reported to have side effects when taking Metronidazole.
Among them, 474 people (1.08%) have Pathogen resistance.
What is Metronidazole?
Metronidazole has active ingredients of metronidazole. It is often used in vaginitis bacterial. eHealthMe is studying from 45,203 Metronidazole users for its effectiveness, alternative drugs and more.
What is Pathogen resistance?
Pathogen resistance is found to be associated with 807 drugs and 521 conditions by eHealthMe.
Number of Metronidazole and Pathogen resistance reports submitted per year:
Time on Metronidazole when people have Pathogen resistance *:
Gender of people who have Pathogen resistance when taking Metronidazole*:
Age of people who have Pathogen resistance when taking Metronidazole *:
Common drugs people take besides Metronidazole *:
Common side effects people have besides Pathogen resistance *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Metronidazole and have Pathogen resistance?
Check whether Pathogen resistance is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of Metronidazole:
- Metronidazole (45,203 reports)
Pathogen resistance treatments and more:
- Pathogen resistance (6,890 reports)
COVID vaccines that are related to Pathogen resistance:
- Pathogen resistance in Moderna COVID Vaccine
- Pathogen resistance in Pfizer BioNTech Covid Vaccine
- Pathogen resistance in Johnson and Johnson Covid Vaccine
How severe was Pathogen resistance and when was it recovered:
Expand to all the drugs that have ingredients of metronidazole:
Common drugs associated with Pathogen resistance:
- Abacavir: 130 reports
- Adefovir dipivoxil: 128 reports
- Amphotericin b: 130 reports
- Ceftazidime: 123 reports
- Ceftriaxone: 114 reports
- Clarithromycin: 419 reports
- Cubicin: 140 reports
- Cyclophosphamide: 162 reports
- Cyclosporine: 138 reports
- Cytarabine: 128 reports
- Darunavir: 211 reports
- Efavirenz: 375 reports
- Emtricitabine: 139 reports
- Fluconazole: 255 reports
- Gentamicin: 185 reports
- Itraconazole: 111 reports
- Linezolid: 218 reports
- Meropenem: 395 reports
- Methotrexate: 171 reports
- Metronidazole: 474 reports
- Mycophenolate mofetil: 238 reports
- Nevirapine: 211 reports
- Piperacillin and tazobactam: 103 reports
- Prednisolone: 202 reports
- Prednisone: 356 reports
- Raltegravir: 147 reports
- Stavudine: 122 reports
- Tacrolimus: 282 reports
- Tenofovir disoproxil fumarate: 420 reports
- Tigecycline: 146 reports
- Voriconazole: 170 reports
All the drugs that are associated with Pathogen resistance:
- Pathogen resistance (807 drugs)
Common conditions associated with Pathogen resistance:
- Cytomegalovirus infection: 136 reports
- H1n1 influenza: 107 reports
- Hepatitis b: 153 reports
- Hiv: 995 reports
- Hiv infection: 995 reports
- Pneumonia: 102 reports
All the conditions that are associated with Pathogen resistance:
- Pathogen resistance (521 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on metronidazole (the active ingredients of Metronidazole) and Metronidazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fluphenazine and Primary Intestinal Pseudo-Obstruction - a second ago
- Mirapex and Sublimaze drug interaction - 3 seconds ago
- Seroquel Xr and Major Depression - 6 seconds ago
- Keflex and Percocet drug interaction - 9 seconds ago
- Pregabalin and Adenocarcinoma - 11 seconds ago